Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Mar 15, 2019; 11(3): 227-237
Published online Mar 15, 2019. doi: 10.4251/wjgo.v11.i3.227
Published online Mar 15, 2019. doi: 10.4251/wjgo.v11.i3.227
Variable | Hepatic resection (n = 80) | RF ablation (n = 63) | P value |
Mean age (yr) | 53.5 ± 9.0 | 60.3 ± 8.7 | < 0.001 |
Male sex | 62 (78) | 49 (78) | 0.968 |
Etiology | 0.042 | ||
HBV | 68 (85) | 43 (68) | |
HCV | 6 (8) | 13 (20) | |
NBNC | 6 (8) | 7 (11) | |
Liver cirrhosis | 50 (63) | 50 (79) | 0.029 |
Tumor size | 2.1 ± 0.6 | 2.1 ± 0.5 | 0.906 |
α-fetoprotein (ng/mL) | 200 ± 489 | 72 ± 165 | 0.031 |
Platelet count (× 103/mm3) | 148 ± 49 | 107 ± 49 | < 0.001 |
Alanine aminotransferase (IU/L) | 41 ± 21 | 40 ± 30 | 0.849 |
Total bilirubin (mg/dL) | 0.7 ± 0.3 | 0.7 ± 0.4 | 0.99 |
Albumin (g/dL) | 4.2 ± 0.4 | 3.9 ± 0.4 | < 0.001 |
Prothrombin time (INR) | 1.1 ± 0.1 | 1.2 ± 0.1 | < 0.001 |
- Citation: Song KD, Lim HK, Rhim H, Lee MW, Kang TW, Paik YH, Kim JM, Joh JW. Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm. World J Gastrointest Oncol 2019; 11(3): 227-237
- URL: https://www.wjgnet.com/1948-5204/full/v11/i3/227.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i3.227